Document Detail


Hip dysplasia following a case of olanzapine exposed pregnancy: a questionable association.
MedLine Citation:
PMID:  16755330     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This is a case report of a 33 year old woman with a history of psychosis, who presented to the women's mental health clinic for consultation at the 12(th) week of gestation, having already received olanzapine throughout the first trimester. She was followed from that point on at our clinic and remained on small doses of olanzapine for the rest of her pregnancy, which was uncomplicated. She gave birth to a healthy female, which at the age of three months was diagnosed with developmental dysplasia of the hip and subsequently received appropriate treatment with favorable outcome. The possibility of the association of this congenital dysplasia with the use of olanzapine during pregnancy is further discussed in this paper.
Authors:
A C Spyropoulou; I M Zervas; C R Soldatos
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2006-06-08
Journal Detail:
Title:  Archives of women's mental health     Volume:  9     ISSN:  1434-1816     ISO Abbreviation:  Arch Womens Ment Health     Publication Date:  2006 Jul 
Date Detail:
Created Date:  2006-07-18     Completed Date:  2006-12-07     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9815663     Medline TA:  Arch Womens Ment Health     Country:  Austria    
Other Details:
Languages:  eng     Pagination:  219-22     Citation Subset:  IM    
Affiliation:
Women's Mental Health Clinic, Department of Psychiatry, Eginition Hospital, University of Athens, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antipsychotic Agents / administration & dosage,  adverse effects*
Benzodiazepines / administration & dosage,  adverse effects
Female
Hip Dislocation, Congenital / chemically induced*,  therapy
Humans
Infant, Newborn
Pregnancy
Pregnancy Complications / drug therapy*
Prenatal Care / methods
Prenatal Exposure Delayed Effects*
Psychotic Disorders / drug therapy*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 12794-10-4/Benzodiazepines; 132539-06-1/olanzapine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Analysis of potential diagnostic biomarkers in cerebrospinal fluid of idiopathic normal pressure hyd...
Next Document:  A partner-rating scale of postpartum depression: the Edinburgh Postnatal Depression Scale - Partner ...